U.S Military HIV Research Program
Morgane Rolland has not added Biography.
If you are Morgane Rolland and would like to personalize this page please email our Author Liaison for assistance.
Characterisation of an Irish caprine lentivirus strain--SRLV phylogeny revisited.
Virus research Apr, 2002 | Pubmed ID: 11955636
Establishment and characterization of a goat synovial membrane cell line susceptible to small ruminant lentivirus infection.
Journal of virological methods Jun, 2004 | Pubmed ID: 15081607
Coping with viral diversity in HIV vaccine design.
PLoS computational biology Apr, 2007 | Pubmed ID: 17465674
Reconstruction and function of ancestral center-of-tree human immunodeficiency virus type 1 proteins.
Journal of virology Aug, 2007 | Pubmed ID: 17537854
HIV-1 over time: fitness loss or robustness gain?
Nature reviews. Microbiology Sep, 2007 | Pubmed ID: 17703224
Recognition of HIV-1 peptides by host CTL is related to HIV-1 similarity to human proteins.
PloS one , 2007 | Pubmed ID: 17786195
HIV-1 group M conserved elements vaccine.
PLoS pathogens Nov, 2007 | Pubmed ID: 18052528
Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads.
PloS one , 2008 | Pubmed ID: 18183304
Characterization of a new 5' splice site within the caprine arthritis encephalitis virus genome: evidence for a novel auxiliary protein.
Retrovirology , 2008 | Pubmed ID: 18312636
HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load.
Journal of virology Jul, 2008 | Pubmed ID: 18434400
Comparison of immunogen designs that optimize peptide coverage: reply to Fischer et al.
PLoS computational biology Jan, 2008 | Pubmed ID: 18463692
Central role of reverting mutations in HLA associations with human immunodeficiency virus set point.
Journal of virology Sep, 2008 | Pubmed ID: 18596105
Viral evolution and escape during primary human immunodeficiency virus-1 infection: implications for vaccine design.
Current opinion in HIV and AIDS Jan, 2008 | Pubmed ID: 19372945
Conserved HIV-1 epitopes continuously elicit subdominant cytotoxic T-lymphocyte responses.
The Journal of infectious diseases Dec, 2009 | Pubmed ID: 19909083
Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics.
PloS one , 2010 | Pubmed ID: 20824187
Viral evolution and escape during acute HIV-1 infection.
The Journal of infectious diseases Oct, 2010 | Pubmed ID: 20846038
Dendritic cells reveal a broad range of MHC class I epitopes for HIV-1 in persons with suppressed viral load on antiretroviral therapy.
PloS one , 2010 | Pubmed ID: 20886040
Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes.
Vaccine Mar, 2011 | Pubmed ID: 21241732
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial.
Nature medicine Mar, 2011 | Pubmed ID: 21358627
Increased breadth and depth of cytotoxic T lymphocytes responses against HIV-1-B Nef by inclusion of epitope variant sequences.
PloS one , 2011 | Pubmed ID: 21464919
Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes.
Journal of virology Aug, 2011 | Pubmed ID: 21593162
Measurements of immune responses for establishing correlates of vaccine protection against HIV.
AIDS research and human retroviruses Jul, 2012 | Pubmed ID: 21861777
Evaluating immune correlates in HIV type 1 vaccine efficacy trials: what RV144 may provide.
AIDS research and human retroviruses Apr, 2012 | Pubmed ID: 21902593
Definition of the viral targets of protective HIV-1-specific T cell responses.
Journal of translational medicine , 2011 | Pubmed ID: 22152067
CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control.
PloS one , 2012 | Pubmed ID: 22238642
MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load.
PloS one , 2012 | Pubmed ID: 22952672
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.
Nature Oct, 2012 | Pubmed ID: 22960785
HIV-1 conserved-element vaccines: relationship between sequence conservation and replicative capacity.
Journal of virology May, 2013 | Pubmed ID: 23468488
HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice.
PloS one , 2013 | Pubmed ID: 23555935
Sieve analysis in HIV-1 vaccine efficacy trials.
Current opinion in HIV and AIDS Sep, 2013 | Pubmed ID: 23719202
Translational research insights from completed HIV vaccine efficacy trials.
Journal of acquired immune deficiency syndromes (1999) Jul, 2013 | Pubmed ID: 23764628
Fitness costs of mutations at the HIV-1 capsid hexamerization interface.
PloS one , 2013 | Pubmed ID: 23785468
Factors affecting relative fitness measurements in pairwise competition assays of human immunodeficiency viruses.
Journal of virological methods Dec, 2013 | Pubmed ID: 23933395
Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques.
PloS one , 2014 | Pubmed ID: 24465991
Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines.
Science translational medicine Mar, 2014 | Pubmed ID: 24648341
HIV-1 conserved elements p24CE DNA vaccine induces humoral immune responses with broad epitope recognition in macaques.
PloS one , 2014 | Pubmed ID: 25338098
CD8 and CD4 epitope predictions in RV144: no strong evidence of a T-cell driven sieve effect in HIV-1 breakthrough sequences from trial participants.
PloS one , 2014 | Pubmed ID: 25350851
Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses.
EBioMedicine Nov, 2014 | Pubmed ID: 25599085
Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial.
PLoS computational biology Feb, 2015 | Pubmed ID: 25646817
Identification of immunodominant CD4-restricted epitopes co-located with antibody binding sites in individuals vaccinated with ALVAC-HIV and AIDSVAX B/E.
PloS one , 2015 | Pubmed ID: 25665096
Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis.
PLoS medicine Apr, 2015 | Pubmed ID: 25849352